儿童急性血源性骨髓炎诊断及药物治疗研究进展  

Research progress in diagnosis and drug treatment of acute hematogenous osteomyelitis in children

作　　者：富洋 王宏胜 陆凤娟 FU Yang;WANG Hongsheng;LU Fengjuan(Department of Hematology,National Children's Medical Center Children's Hospital of Fudan University,Shanghai 201102,China;Department of Pediatric Rehabilitation,Shanghai Xinqidian Rehabilitation Hospital,Shanghai 201107,China)

机构地区：[1]国家儿童医学中心复旦大学附属儿科医院血液科,上海201102 [2]上海新起点康复医院儿童康复科,上海201107

出　　处：《世界临床药物》2023年第1期90-93,共4页World Clinical Drug

摘　　要：儿童急性血源性骨髓炎是儿童骨骼肌肉系统感染中最常见的一类疾病,多由金黄色葡萄球菌感染引起,破坏性强,如延误治疗,可能会导致深静脉血栓形成、心内膜炎以及感染性休克等并发症,远期可导致骨缺血性坏死、病理性骨折、畸形、活动受限及影响生长发育等后遗症。因此早期准确的诊断与及时合理的治疗非常关键。该文就儿童急性血源性骨髓炎诊断与药物治疗的研究进展作一综述,以利于提高治疗的规范性与疗效。Acute hematogenous osteomyelitis in children is the most common disease of skeletal muscle system infection in children.It is mainly caused by Staphylococcus aureus infection and has a strong destructive effect.Delayed treatment may lead to deep vein thrombosis,endocarditis and septic shock and other complications.In the long term,it may lead to bone ischemic necrosis,pathological fracture,deformity,activity restriction and affect growth and development and other sequelae.Therefore,early and accurate diagnosis and timely and reasonable treatment are very important.This article reviews the research progress in diagnosis and drug treatment of acute hematogenous osteomyelitis in children,in order to improve the standardization and therapeutic effect of treatment.

关 键 词：急性血源性骨髓炎 儿童 诊断 治疗 

分 类 号：R725.1[医药卫生—儿科] R726.8[医药卫生—临床医学]